At Verastem Oncology, we're advancing innovation and addressing the urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. The FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy specifically for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve successfully launched this innovative combination therapy in the U.S. and are exploring regulatory pathways for Europe and Japan. We are continuing to advance our pipeline of drugs that we believe will help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. With clinical trials underway, we have an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients. Summary: This position is responsible for development and drug substance manufacturing activities of new and existing products at external Contract Manufacturing Organizations (CMOs). Activities include but not limited to drug substance synthetic process design, scale up, technology transfer, process validation, testing, analysis, and interpretation of data of varying complexity. In this cross functional role, he/she works directly with Analytical, formulation Chemistry, Supply Chain, Quality and Regulatory teams at Verastem. Position reports directly to VP, CMC. The ideal candidate for this position would be an individual with a growth mindset who is looking for high impact contribution and the opportunity to learn and expands beyond his/her current knowledge and skills.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree